Pajjiż: Irlanda
Lingwa: Ingliż
Sors: HPRA (Health Products Regulatory Authority)
Alfacalcidol
LTT Pharma Limited
A11CC; A11CC03
Alfacalcidol
1 microgram(s)
Capsule, soft
Product subject to prescription which may be renewed (B)
Vitamin D and analogues; alfacalcidol
Authorised
2014-12-05
These are signs that there may be problems developing with your kidneys. Kidney stones may be forming. Kidney stones may cause a sharp spasm or pain in one side of your lower back. RARE POSSIBLE SIDE EFFECTS WHICH MAY AFFECT UP TO 1 IN 1,000 PEOPLE ARE: • Dizziness REPORTING OF SIDE EFFECTS If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via HPRA Pharmacovigilance, Earlsfort Terrace, IRL – Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; e-mail: medsafety@hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine. 5. HOW TO STORE ONE-ALPHA ® • Keep this medicine out of the sight and reach of children. • Do not store above 25°C. • Do not use this medicine after the expiry date which is stated on the carton and foil blister (EXP). The expiry date is the last day of that month. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment. 6. CONTENTS OF THE PACK AND OTHER INFORMATION WHAT ONE-ALPHA ® CONTAINS The active substance, which treats your illness is alfacalcidol. One-Alpha ® 1 microgram capsule contains 1 microgram of alfacalcidol. The other ingredients in One-Alpha® 1 microgram capsules are: sesame oil, all-rac-α-tocopherol, gelatin, glycerol, potassium sorbate and ferric oxide (E172). You can find important information about some of the ingredients in your medicine near the end of section 2 of this leaflet. WHAT ONE-ALPHA ® LOOKS LIKE AND CONTENTS OF THE PACK One-Alpha ® 1 microgram soft capsules are brown, egg shaped, soft capsules. The capsules come in blister packs of 30 soft capsules. THE PARALLEL PRODUCT AUTHORISATION HOLDER IS: LTT Pharma Limited, Unit 18, Oxleasow Road, East Moons Moat, Redditch, Worcestershire, B98 0RE, UK. REPACKAGED BY: Lexon (UK) Limited Aqra d-dokument sħiħ
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT One-Alpha 1 microgram soft capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 1 microgram of alfacalcidol. Excipient(s) with known effects: contains Sesame Oil. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Capsule, soft (capsule). _Product imported from Greece._ Brown, egg-shaped soft gelatin capsule, holding 0.1g oily solution. 4 CLINICAL PARTICULARS As per PA 0046/024/001 5 PHARMACOLOGICAL PROPERTIES As per PA 0046/024/001 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Sesame oil All-rac- -tocopherol Gelatin Glycerol Potassium sorbate Ferric oxide (E172) 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf life expiry date of this product shall be the date shown on the blister and outer package of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25°C. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _0_ _8_ _/_ _1_ _2_ _/_ _2_ _0_ _1_ _4_ _C_ _R_ _N_ _ _ _2_ _1_ _5_ _4_ _7_ _9_ _2_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 6.5 NATURE AND CONTENTS OF CONTAINER Al/PVC blister foil, polyamide/Al lid containing 30 capsules. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT No special requirements. Any unused medicinal product or waste material should be disposed of in accordance wi Aqra d-dokument sħiħ